Teachers Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Teachers Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$4.1M	Buy	55,956 +13,681	+32%	+$931K	0.01%	1547
2018 Q4	$1.79M	Buy	42,275 +3,095	+8%	+$123K	﹤0.01%	1907
2018 Q3	$1.84M	Buy	39,180 +4,547	+13%	+$253K	﹤0.01%	2009
2018 Q2	$1.71M	Buy	+34,633	New	+$1.31M	﹤0.01%	2038
2017 Q2	–	Sell	-23,097	Closed	-$120K	–	3186
2017 Q1	$120K	Buy	23,097 +4,311	+23%	+$23.6K	﹤0.01%	2959
2016 Q4	$89K	Buy	18,786 +4,348	+30%	+$23.7K	﹤0.01%	3022
2016 Q3	$95K	Sell	14,438 -2,029	-12%	-$10.8K	﹤0.01%	3010
2016 Q2	$90K	Hold	16,467	–	–	﹤0.01%	3046
2016 Q1	$352K	Hold	16,467	–	–	﹤0.01%	2535
2015 Q4	$520K	Buy	16,467 +2,002	+14%	+$70.7K	﹤0.01%	2386
2015 Q3	$498K	Hold	14,465	–	–	﹤0.01%	2400
2015 Q2	$455K	Buy	14,465 +3,026	+26%	+$89.2K	﹤0.01%	2580
2015 Q1	$335K	Buy	11,439 +1,181	+12%	+$27.7K	﹤0.01%	2667
2014 Q4	$190K	Hold	10,258	–	–	﹤0.01%	2920
2014 Q3	$180K	Hold	10,258	–	–	﹤0.01%	2929
2014 Q2	$205K	Buy	+10,258	New	+$198K	﹤0.01%	2917

Other funds holding MRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Teachers Advisors's MRTX Position: Q1 2019 in Review

Teachers Advisors increased its Mirati Therapeutics, Inc. Common Stock (MRTX) stake by 32% in Q1 2019, buying an estimated $931K and bringing the position to 55,956 shares worth $4.1M. The position accounts for 0.01% of the portfolio, ranked #1547.

Teachers Advisors first reported a position in MRTX in Q2 2014 and has held it in 16 quarters since. 159 funds tracked by Wall St. Rank hold MRTX as of Q1 2019.

Teachers Advisors held 55,956 shares of Mirati Therapeutics, Inc. Common Stock worth $4.1M as of Q1 2019.
Teachers Advisors bought 13,681 Mirati Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $931K.
Mirati Therapeutics, Inc. Common Stock made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1547 holding.
Teachers Advisors first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2014 and has held it in 16 quarters since.
159 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.